28
Symptom Control in Palliative Care Cathy Corden GP VTS ST1

Symptom Control in Palliative Care

  • Upload
    clint

  • View
    56

  • Download
    1

Embed Size (px)

DESCRIPTION

Symptom Control in Palliative Care. Cathy Corden GP VTS ST1. Case Study 1. Mrs AB 68 year old lady Ca breast with metastatic disease Worsening pain in back, cannot get comfortable at all Nauseous, lethargic and her daughter feels she has become more confused recently. - PowerPoint PPT Presentation

Citation preview

Page 1: Symptom Control in Palliative Care

Symptom Control in Palliative Care

Cathy CordenGP VTS ST1

Page 2: Symptom Control in Palliative Care

Case Study 1

Mrs AB 68 year old lady Ca breast with metastatic disease Worsening pain in back, cannot get

comfortable at all Nauseous, lethargic and her

daughter feels she has become more confused recently.

On paracetamol 1 gram qds, codeine 30mg qds

Page 3: Symptom Control in Palliative Care

Case Study 1

What are the main issues in this case? What investigations might you want to

carry out? Is there anything else you would want to

know to help make decisions? If all investigations normal, what would be

the next management steps for pain control?

Page 4: Symptom Control in Palliative Care

Spinal Cord Compression

Back pain most often thoracic Weakness of lower limbs Sensory level Urinary symptoms

Up to 5% cancer sufferersCa prostate, breast, bronchus,

myeloma

Page 5: Symptom Control in Palliative Care

Spinal Cord Compression

http://intqhc.oxfordjournals.org/content/19/6/377.full

Page 6: Symptom Control in Palliative Care

Spinal Cord Compression cont

GP can start dexamethasone 16mg/day whilst referring urgently to oncology/spinal centre

MRI scan Radiotherapy Spinal surgery

Page 7: Symptom Control in Palliative Care

Hypercalcaemia

10-20% advanced cancer Myeloma, breast, renal, squamous

cell carcinomas Nausea, vomiting, confusion,

constipation, thirst, fits, coma. More commonly caused by

parathyroid hormone-related peptide secreting tumour rather than lytic metastases

Page 8: Symptom Control in Palliative Care

Hypercalcaemia cont

Symptoms appear when calcium rises quickly and over 3.0 mmol/L

Admit for fluids and IV bisphosphonates

May require PO bisphosphonates to reduce recurrence rates.

Page 9: Symptom Control in Palliative Care

Bony metastases

Significant pain Pathological fractures Analgesia Radiotherapy Bisphosphonates Surgical inj steroids/anaesthetics

Page 10: Symptom Control in Palliative Care

WHO analgesic ladder

Page 11: Symptom Control in Palliative Care

Opioid Analgesia

Immediate release e.g. oramorph. Work within 20mins and last 4 hours.

Modified release e.g. Zomorph, MST MR.

Start 10 mg immediate release 4 hourly and increase by 30-50% every 3 days until pain relief achieved/SEs. Beware elderly pts.

Page 12: Symptom Control in Palliative Care

Opioid Analgesia

Once stable pain control transfer to modified release preparation.

Need immediate release preparation for breakthrough pain. Should be 1/6 total dose e.g. if taking 60 mg MST bd would need 20 mg oramorph 4 hourly.

Remember the laxative, antiemetic

Page 13: Symptom Control in Palliative Care

Case Study 2

Mrs CD 56 year old ladyMetastatic ovarian carcinomaContinuous vomiting last 4 daysIntermittant bowel obstruction. Last opened

bowels 3 days ago. Abdominal painOn MST 60 mg bd, oramorph prn,

metoclopramide 10mg tds POWishes not to go back to hospital as does

not want NG tube/prolonged hospital stay

Page 14: Symptom Control in Palliative Care

Case Study 2

You decide to set up a syringe driver at home.

What are the common reasons for using syringe driver?

What medications could you choose, what dosages?

As a GP how do you order syringe drivers? What is the important info needed on prescription?

Page 15: Symptom Control in Palliative Care

Syringe Drivers

Persistent vomiting

Reduced level consciousness

Weak Dysphagia Forgets to take

PO medication Last days of life

Page 16: Symptom Control in Palliative Care

Pain Control

Diamorphine s/c To convert from oral morphine to s/c

diamorphine ratio is 3:1 On MST 60 mg bd, 40 mg oramorph

in 24 hours therefore total morphine 160 mg. Diamorphine dose in 24 hours would be just over 50mg.

Page 17: Symptom Control in Palliative Care

Vomiting

www.yorkshire-cancer-net.org.uk/

Page 18: Symptom Control in Palliative Care

Ordering Syringe Drivers

Medication in words and numbers if controlled drugs

Made up to 15 ml with water for injection

To run over 24 hours Aseptic services – part of pharmacy D/W district nurses Need to sign pink form for DN to set

up driver.

Page 19: Symptom Control in Palliative Care

Syringe Drivers

Diamorphine can be combined with any of the following in a driver:

Cyclizine Haloperidol Hyoscine Hydrobromide Hyoscine Butylbromide Levomepromazine Metoclopramide Midazolam

Page 20: Symptom Control in Palliative Care

Case Study 3

79 year old gentleman Ca bronchus Struggling with dyspnoea. His wife

tells you that he has been deteriorating rapidly last two days and is now very agitated.

On home oxygen

Page 21: Symptom Control in Palliative Care

Case Study 3

What are the common causes of dyspnoea in someone who is palliative?

How would you manage a patient such as this? Consider:

- dyspnoea - agitation

Page 22: Symptom Control in Palliative Care

Dyspnoea

Uncomfortable awareness of breathing. Frightening.

Common in end stage COPD, cardiac failure, cancer, neurological conditions

Rule out COPD exacerbation, PE, pulmonary oedema, pneumonia, SVCO, anaemia, pleural effusion, ascites, lung mets, lymphangitis carcinomatosa

Page 23: Symptom Control in Palliative Care

Superior Vena Caval Obstruction

SOB Swelling face,

arms Collateral veins Dizziness Visual changes Headache Urgent referral

with high dose dexamethasone

http://www.bmj.com/content/315/7121/1525.extract

Page 24: Symptom Control in Palliative Care

Dyspnoea

O2 Optimise bronchodilators in COPD Use fan/open window to ease

sensation Position upright Physiotherapy Good oral care

Page 25: Symptom Control in Palliative Care

Dyspnoea

Oramorph 2.5 mg 4 hourly. Titrate up. Not used enough for dyspnoea for fear of respiratory depression. However very effective.

Diamorphine s/c Midazolam 2.5 mg s/c anxiety/fear

suffocation.

Page 26: Symptom Control in Palliative Care

Agitation

Pain Urinary retention Constipation Anxiety Uncomfortable positioning Nausea/vomiting SE medication Cerebral irritation

Page 27: Symptom Control in Palliative Care

Agitation

Once all above reversible causes have been excluded likely terminal agitation.

Levomepromazine 12.5-25.0 mg s/c 4-6 hourly, 25-150 mg s/c 24 hours.

Midazolam 2.5-5.0 mg s/c 4 hourly, 10-60mg s/c 24 hours.

Page 28: Symptom Control in Palliative Care

References

Oxford Handbook of Palliative Care Derby Hospitals: Syringe Driver

Combinations from CASU www.bathgped.co.uk/presentations www.yorkshire-cancer-net.org.uk/